AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
MORPHINE
27 registrations across 5 African markets— 13 active
Markets with MORPHINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| MORPHINE MEDIS Solution injectable / 10MG/ML | 🇹🇳Tunisia | LES LABORATOIRES MEDIS | expired | Sept 2020 |
| MORPHINE (CHLORHYDRATE) RENAUDIN Solution injectable / 10 mg/ml | 🇹🇳Tunisia | RENAUDIN | expired | Aug 2020 |
| MOSCONTIN 60 Comprimé à libération prolongée / 60 MG | 🇹🇳Tunisia | Napp Pharmaceuticals Limited | expired | Feb 2016 |
| MOSCONTIN 10 Comprimé à libération prolongée / 10 MG | 🇹🇳Tunisia | Napp Pharmaceuticals Limited | expired | Feb 2016 |
| MOSCONTIN 100 Comprimé à libération prolongée / 100 MG | 🇹🇳Tunisia | Napp Pharmaceuticals Limited | expired | Feb 2016 |
| MOSCONTIN 200 Comprimé à libération prolongée / 200 MG | 🇹🇳Tunisia | Napp Pharmaceuticals Limited | expired | Feb 2016 |
| MOSCONTIN 30 Comprimé à libération prolongée / 30 MG | 🇹🇳Tunisia | Napp Pharmaceuticals Limited | expired | Feb 2016 |
| SKENAN LP Gélule à libération prolongée / 60 MG | 🇹🇳Tunisia | ETHYPHARM | expired | Feb 2016 |
| SKENAN LP Gélule à libération prolongée / 30 MG | 🇹🇳Tunisia | ETHYPHARM | expired | Feb 2016 |
| SKENAN LP Gélule à libération prolongée / 100 mg | 🇹🇳Tunisia | ETHYPHARM | expired | Feb 2016 |
| SKENAN LP Gélule à libération prolongée / 10 MG | 🇹🇳Tunisia | ETHYPHARM | expired | Feb 2016 |
| MORPHINE CHLORHYDRATE AGUETTANT Solution injectable / 0.1 mg/ml | 🇹🇳Tunisia | LABORATOIRE AGUETTANT | expired | May 2009 |
| MORPHINE CHLORHYDRATE AGUETTANT Solution injectable / 10 mg/ml | 🇹🇳Tunisia | LABORATOIRE AGUETTANT | expired | May 2009 |
| MORPHINE (CHLORHYDRATE) RENAUDIN Solution injectable / 10 mg/ml | 🇹🇳Tunisia | RENAUDIN | expired | Nov 2003 |
| MORPHINE MERAM 1% SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| MOSCONTIN COMPRIME LP | 🇲🇦Morocco | — | active | — |
| MORPHINE BIOTIS PHARMA ampoule injectable / 1% | 🇸🇳Senegal | BIOTIS PHARMA | active | — |
| SEVREDOL COMPRIME PELLICULE SECABLE | 🇲🇦Morocco | — | active | — |
| Vermor - 10 Solution | 🇹🇿Tanzania | VERVE HUMAN CARE LABORATORIES | active | — |
| MOSCONTIN COMPRIME LP | 🇲🇦Morocco | — | active | — |
| MORPHINE SOTHEMA 30MG/ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| MOSCONTIN COMPRIME LP | 🇲🇦Morocco | — | active | — |
| MORPHINE SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| MORPHINE PARENTERAL
ORDINARY
AMPOULES | 🇺🇬Uganda | MARTINDALE AND AURUM PHARMACEUTICA L | active | — |
| MORPHINE PARENTERAL
ORDINARY
AMPOULES | 🇺🇬Uganda | MARTINDALE AND AURUM PHARMACEUTICA L | active | — |
| SEVREDOL COMPRIME PELLICULE SECABLE | 🇲🇦Morocco | — | active | — |
| MOSCONTIN COMPRIME LP | 🇲🇦Morocco | — | active | — |
MORPHINE in Africa — Regulatory Overview
MORPHINE is registered across 5 African markets with 27 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Uganda, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 27 registrations, 13 (48%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.